Immune response: A possible role in the pathophysiology of hemangioma

Medical Hypotheses

Volumn 68, Issue 2, 2007, Pages 353-355

  Sun, Zhi Jun ^a,b   Zhao, Yi Fang ^a   Zhang, Wen Feng ^a,b  

^a WUHAN UNIVERSITY   (China)

^b Wuhan University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; FC RECEPTOR; IMIQUIMOD; INDOLEAMINE 2,3 DIOXYGENASE;

ARTICLE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; ENDOTHELIUM CELL; HEMANGIOMA; HUMAN; HYPOTHESIS; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; IMMUNOSURVEILLANCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TUMOR CELL; TUMOR REGRESSION;

AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; CD4-POSITIVE T-LYMPHOCYTES; HEMANGIOMA; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; LYMPHANGIOMA;

EID: 33845313925     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.07.013     Document Type: Article

References (14)

1. Enjolras O., and Mulliken J.B. Vascular tumors and vascular malformations (new issues). Adv Dermatol 13 (1997) 375-423
2. Mulliken J.B., Fishman S.J., and Burrows P.E. Vascular anomalies. Curr Probl Surg 37 (2000) 517-584
3. Hamlat A., Adn M., Pasqualini E., et al. Pathophysiology of capillary haemangioma growth after birth. Med Hypotheses 64 (2005) 1093-1096
4. Yu Y., Flint A.F., Mulliken J.B., et al. Endothelial progenitor cells in infantile hemangioma. Blood 103 (2004) 1373-1375
5. Ritter M.R., Reinisch J., Friedlander S.F., et al. Myeloid cells in infantile hemangioma. Am J Pathol 168 (2006) 621-628
6. Tan S.T., Wallis R.A., He Y., et al. Mast cells and hemangioma. Plast Reconstr Surg 113 (2004) 999-1011
7. Ritter M.R., Moreno S.K., Dorrell M.I., et al. Identifying potential regulators of infantile hemangioma progression through large-scale expression analysis: a possible role for the immune system and indoleamine 2,3 dioxygenase (IDO) during involution. Lymphat Res Biol 1 (2003) 291-299
8. Frumento G., Rotondo R., Tonetti M., et al. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med 196 (2002) 459-468
9. Friedlander S.F., Ritter M.R., and Friedlander M. Recent progress in our understanding of the pathogenesis of infantile hemangiomas. Lymphat Res Biol 3 4 (2005) 219-225
10. North P.E., Waner M., Mizeracki A., et al. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol 137 (2001) 559-570
11. Gessner J.E., Heiken H., Tamm A., et al. The IgG Fc receptor family. Ann Hematol 76 (1998) 231-248
12. Martinez M.I., Sanchez-Carpintero I., North P.E., et al. Infantile hemangioma: clinical resolution with 5% imiquimod cream. Arch Dermatol 138 (2002) 881-884
13. Sidbury R., Neuschler N., Neuschler E., et al. Topically applied imiquimod inhibits vascular tumor growth in vivo. J Invest Dermatol 121 (2003) 1205-1209
14. Sterescu A.E., Rousseau-Harsany E., Farrell C., et al. The potential efficacy of omega-3 fatty acids as anti-angiogenic agents in benign vascular tumors of infancy. Med Hypotheses 66 (2006) 1121-1124